Studies on the stability of a human adenovirus-rabies recombinant vaccine.
Human adenovirus type 5 containing the rabies virus glycoprotein gene (rHAd-RG1) has potential for the oral vaccination of animals. The stability of this recombinant was tested indoors and outdoors by measuring the loss in virus infectivity. Under indoor conditions the stability of the recombinant virus was studied in an egg yolk-containing commercial stabilizer and a simple buffered salt solution (EBSS; Earle's balanced salt solution) at 4 degrees C and room temperature (24-25 degrees C). Over 16 days, there was a more rapid loss in virus titer at room temperature than at 4 degrees C in both suspending media; however, these differences were slight and may be significant when the overall stability of the vaccine is considered. When the virus was mixed with either 10% (w/v) fox or skunk feces or EBSS, placed on stainless steel disks and the disks kept under ambient conditions (air temperature 24-25 degrees C; relative humidity 45-50%), there was a more rapid decline in virus titer in the fecal suspensions (3% remained after 72 h) than in EBSS (26% remained after 72 h). When bait-coated blister packs of the vaccine were placed in an outdoor location in the fall (October) season, there was a larger drop in the virus titer for vaccines placed in the sun (54% over 32 days) than for those in the shade (40% over 32 days). Incorporating proteinaceous stabilizers in the vaccine samples for outdoor study showed virus stability was not enhanced in their presence.(ABSTRACT TRUNCATED AT 250 WORDS)
Kalicharran
K K
KK
Department of Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ontario.
Springthorpe
V S
VS
Sattar
S A
SA
D000260:Adenoviruses, Human / Q000235:genetics*; D000818:Animals; D004355:Drug Stability; D005243:Feces / Q000382:microbiology; D006207:Half-Life; D011309:Preservation, Biological; D011819:Rabies Vaccines / Q000592:standards*; D013472:Sunlight; D013696:Temperature; D014614:Vaccines, Synthetic; D014709:Vero Cells
D011819:Rabies Vaccines; D014614:Vaccines, Synthetic